Original document(189 pages)  中文版
    Hydroxy (tetra- or hexa-)hydronaphthyridine dione compounds of Formula (I) are inhibitors of HIV integrase and inhibitors of HIV replication wherein X<1>, X<2>, R<4> and R<5> are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
Application Number
申请号
200580007404 Application Date
申请日
2005.03.09
Title 名称 HIV integrase inhibitors
Publication Number
公开号
1930160 Publication Date
公开日
2007.03.14
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D471/04;A61K31/4375;A61P31/12;A61P37/02
Applicant(s) Name
申请人
Merck & Co. Inc.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 machong de zouxue mei
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.